OBJECTIVES To compare the Risk-Sharing Schemes (RSSs) proposed in reimbursement applications received by Agency for Health Technology Assessment in Poland (AHTAPol) in 2012 and 2013. METHODS Comparative analysis of RSSs proposed in reimbursement applications received by AHTAPol in 2012 and 2013 was conducted. RSSs were quantitatively and qualitatively analyzed and classified on the basis of both Carlson’s approach and the Polish Act on the reimbursement of medicinal products. RESULTS In years 2012 and 2013, 56 reimbursement applications with 26 proposed RSSs and 80 reimbursement applications with 52 RSSs proposed received by AHTAPol, respectively. They were classified into 5 categories according to the Act on the reimbursement. The most common category in 2012 was making the official sales price dependent on the applicant providing supplies at a reduced price (34.62%). On the other hand, in 2013 the most common category was making the official sales price dependent on a pay-back of a part of the reimbursement obtained to the entity which is obliged to finance benefits with public funds (48.08%). Further categories were also analyzed. Among all RSSs proposed in each year, only 17 of 52 in 2013 and 9 of 26 (1 proposition included more than one category) in 2012 could be classified according to the Carlson’s approach. As a results, most common categories were Price Volume Agreements (4 in 2012 and 10 in 2013) and Manufacturer funded treatment initiation (4 in 2012 and 6 in 2013). Both in 2012 and 2013, there were only one RSSs dependent on the health effects achieved. CONCLUSIONS Most of the propositions both in 2012 and 2013 are not considered to be RSS according to the Carlson’s approach. In 2013 compared to 2012 there were less price reduction schemes and more pay-back based schemes. There is a strong need for further research.